Abstract
Executive Summary
Cancer vaccines offer an attractive therapeutic addition, delivering treatment
of high specificity, low toxicity and prolonged activity. However, despite
years of R&D, a reproducible survival benefit has proved elusive, leaving the
market wide open.
There are today at least 210 cancer vaccines, from early preclinical to
marketed drugs. In addition, the accumulated number of ceased drugs over the
last three years amount to another 165 drugs. Cancer Vaccines Drug Pipeline
Update lists all drugs and gives you a progress analysis on each one of them.
Identified drugs are linked to 133 different targets. These targets are
further categorized on the CD-ROM by 44 classifications of molecular function
and with pathway referals to BioCarta, KEGG and NetPath. Read more below on
how the Cancer Vaccines Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click
from inside the application and you may search the World Wide Web and PubMed
for any drug.
Drug Pipeline Update is delivered to you as a CD-ROM application, which
requires no installation on your computer.
| 
View Cart
